AdvisorShares Psychedelics ETF (PSIL)
NYSEARCA: PSIL · Real-Time Price · USD
23.56
+0.02 (0.08%)
Jul 27, 2026, 11:12 AM EDT - Market open
PSIL Holdings Information
PSIL is an equity ETF with a total of 34 individual holdings. The top holdings are AtaiBeckley stock at 13.83%, Definium Therapeutics at 11.63%, COMPASS Pathways at 9.92%, NRx Pharmaceuticals at 6.05%, and Cybin at 5.48%.
Total Holdings
34
Top 10 Percentage
69.96%
Asset Class
Equity
ETF Category
Miscellaneous Sector
Assets
50.70M
PE Ratio
n/a
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ATAI | AtaiBeckley Inc. | 13.83% |
| 2 | DFTX | Definium Therapeutics, Inc. | 11.63% |
| 3 | CMPS | COMPASS Pathways plc | 9.92% |
| 4 | NRXP | NRx Pharmaceuticals, Inc. | 6.05% |
| 5 | NEO: HELP | Cybin Inc. | 5.48% |
| 6 | RLMD | Relmada Therapeutics, Inc. | 5.09% |
| 7 | GHRS | GH Research PLC | 4.64% |
| 8 | NBIX | Neurocrine Biosciences, Inc. | 4.48% |
| 9 | ANRO | Alto Neuroscience, Inc. | 4.42% |
| 10 | ABBV | AbbVie Inc. | 4.41% |
| 11 | ALKS | Alkermes plc | 4.31% |
| 12 | CSE: DRUG | Bright Minds Biosciences Inc. | 4.08% |
| 13 | JNJ | Johnson & Johnson | 3.86% |
| 14 | STIM | Neuronetics, Inc. | 3.12% |
| 15 | SUPN | Supernus Pharmaceuticals, Inc. | 2.91% |
| 16 | NEUP | Neuphoria Therapeutics Inc. | 2.21% |
| 17 | CSE: QNTM | Quantum BioPharma Ltd. | 1.48% |
| 18 | OPTI.NE | Optimi Health Corp | 1.30% |
| 19 | LLY | Eli Lilly and Company | 1.26% |
| 20 | KTTA | Pasithea Therapeutics Corp. | 1.00% |
| 21 | n/a | Blackrock Treasury Trust Instl 62 | 0.92% |
| 22 | TSX: NUMI | Numinus Wellness Inc. | 0.90% |
| 23 | PBM | Psyence Biomedical Ltd. | 0.77% |
| 24 | SILO | Silo Pharma, Inc. | 0.75% |
| 25 | IXHL | Incannex Healthcare Inc. | 0.43% |
As of Jul 23, 2026